Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-113-0 | CAS number: 10035-10-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://chesar.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Though there are minimal animal repeated dose data on hydrogen bromide (HBr) available (supporting study provided in Section 8.6.1: 20-day repeated inhalation study in the rat), there are sufficient data available on the analogue substance hydrogen chloride (HCl) (Section 8.6.2; inhalation exposure) to indicate an appropriate level for hazard identification for the main route of exposure (i.e., inhalation). The available data on the analogue HCl have been used for indication of an EU Indicative Occupational Exposure Level value (IOELV) for HBr given in Directive 2000/39/EC (15 minute IOELV limit = 6.7 mg/m3 or 2 ppm). Additional routes of exposure (i.e., oral or dermal) are not considered as appropriate routes for determination of repeated dose toxicity.
Inhalation exposure to phosphorus tribromide may also be used as an indication of HBr toxicity. PBr3 reacts with moisture in the air and on wet surfaces to produce phosphonic acid and hydrogen bromide gas (HBr). The hydrolysis rate for this reaction is 4 x 10-17 cm2/s. At a relative humidity of 5%, hydrolysis half-life is 810 milliseconds. This decreases to 81 milliseconds at 50% RH, and 41 milliseconds for 100% RH.
HBr is a substance that rapidly undergoes changes in contact with moisture – either in the air or in contact with respiratory or oral tissues. (See Annex VIII Section 9.2.2.1 Hydrolysis). HBr is generally unmeasurable in the body as it changes directly to hydrobromic acid in water forming hydrogen and bromide ions. In air, it may form bromine, but the reaction pathway ultimately ends with the formation of bromide ions (Annex VIII Section 8.8.1 Toxicokinetics assessment). It is generally accepted that bromide is the chemical moiety of concern for long-term assessment of systemic HBr toxicity.
Key value for chemical safety assessment
Additional information
HBr is a highly reactive substance which is well known to cause burns to skin and eyes. It is classified/labelled with the symbols “C” and “Xi” and the risk phrases “R35” and “R37”.
Though there are minimal animal repeated dose data on HBr available (supporting study provided in Section 8.6.1: 20-day repeated inhalation study in the rat), there are sufficient data available on the analogue substance HCl (Section 8.6.2; inhalation exposure) to indicate an appropriate level for hazard identification for the main route of exposure (i.e., inhalation). The available data on the analogue HCl have been used for indication of an EU Indicative Occupational Exposure Level value (IOELV) for HBr given in Directive 2000/39/EC (15 minute IOELV limit = 6.7 mg/m3or 2 ppm). Additional routes of exposure (i.e., oral or dermal) are not considered as appropriate routes for determination of repeated dose toxicity.
Inhalation exposure to phosphorus tribromide may also be used as an indication of HBr toxicity. PBr3 reacts with moisture in the air and on wet surfaces to produce phosphonic acid and hydrogen bromide gas (HBr) according to the following reaction:
PBr3+ 3 H2O → 3 HBr + H3PO3
The hydrolysis rate for this reaction is 4 x 10-17 cm2/s. At a relative humidity of 5%, hydrolysis half-life is 810 milliseconds. This decreases to 81 milliseconds at 50% relative humidity (RH), and 41 milliseconds for 100% RH. As the diffusion of PBr3 vapour is very slow, given the high hydrolysis rate, PBr3 would be expected to travel less than 1 cm from a pool of liquid before reacting. Thus, inhalation exposure to PBr3 can be considered analogous to HBr exposure.
HBr is a substance that rapidly undergoes changes in contact with moisture – either in the air or in contact with respiratory or oral tissues. (See Annex VIII Section 9.2.2.1 Hydrolysis). HBr is generally unmeasurable in the body as it changes directly to hydrobromic acid in water forming hydrogen and bromide ions. In air, it may form bromine, but the reaction pathway ultimately ends with the formation of bromide ions (Annex VIII Section 8.8.1 Toxicokinetics assessment). It is generally accepted that bromide is the chemical moiety of concern for long-term assessment of systemic HBr toxicity.
Sub-acute
Wolfe, R.E.,et al. (1997) reported that in a 28-day study in Fischer 344 rats exposed to phosphorus tribromide (PBr3) (which hydrolyses into HBr and phosphonic acid) for 4 hours per day, five days per week, at dose levels of 0.03, 0.1 or 0.3 mg/L showed no signs of toxic stress, alterations of body weight, or changes in organ weights compared to control animals. Minor serum chemistry and hematology effects were seen in treated animals. Microscopic tissue findings were limited to rats of the 0.3 mg/L group and consisted of mild inflammation of the nasal passages. A concentration of 0.1 mg/L was the no observable adverse effect level (NOAEL) in a 28-day inhalation study.
In a separate 5-day study, Wolfe, R.E.,et al., (1997) reported that five exposures of rats for 4 hours per day to PBr3 causing no deaths or signs of toxic stress at concentrations up to 0.51 mg/L PBr3(equivalent to 0.467 mg/L HBr). Mean body weights decreased in all groups (including control animals) over the 5 exposure days. Weights were statistically lower in the high dose group compared to control on days 3 and 4. Several mean values of serum chemistries and hematology values differed in treated animals compared to control. Increases in serum chloride were thought to be analytical interference by presence of serum bromide. Increased values in calcium and potassium were seen in the high-dose group/ Decreased alkaline phosphatase and creatine kinase values were seen in the high-dose group; and ALT values were increased in the 0.16 and 0.51 mg/L groups. The high-dose group showed gross lesions as irregularly shaped and reddened nares. There were no statistically different absolute or relative organ weights between control and exposed animals. Microscopic lesions were seen in the high dose group in the most anterior segment of the nasal passages. Lesions consisted of suppurative inflammation of the nasal mucosa. One high dose animal had minimal squamous metaplasia of the respiratory epithelium of the trachea. In the mid dose group, one animal had slight inflammation of the anterior nasal mucosa. There were no microscopic lesions in the low dose or control animals.
Sub-chronic
In a 90-day repeated inhalation dose study with HCl, summarised by OEHHA (2007), several animals died during the study, although the deaths were not considered to be exposure related. A slight but significant decrease in body weight gain was reported in male and female mice and in male Fischer 344 rats in the high-exposure groups. No effects were noted in hematology, clinical chemistry, or urinalysis. Minimal or mild rhinitis was observed in both strains of rats. Concentration- and time-related lesions were noted in the anterior portion of the nasal cavity of exposed rats. Cheilitis, eosinophilic globules in the nasal epithelium, and accumulation of macrophages in the peripheral tissues were observed in mice of all exposed groups. The 90-day LOAEL derived from the study is 10 ppm for both mice and rats.
Justification for classification or non-classification
HBr is a highly reactive substance which is well known to cause burns to skin and eyes. It is classified/labelled with the symbols “C” and “Xi” and the risk phrases “R35” and “R37”.
HBr is generally unmeasurable in the body as it changes directly to hydrobromic acid in water forming hydrogen and bromide ions. In air, it may form bromine but the reaction pathway ultimately ends with the formation of bromide ions (Annex VIII Section 8.8.1 Toxicokinetics assessment). It is generally accepted that bromide is the chemical moiety of concern for long-term assessment of systemic HBr toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)